Immunovant
IMVT
#3621
Rank
NZ$4.80 B
Marketcap
$28.28
Share price
8.03%
Change (1 day)
-45.16%
Change (1 year)

Market capitalization of Immunovant (IMVT)

Market cap: NZ$4.80 Billion

As of April 2025 Immunovant has a market cap of NZ$4.80 Billion. This makes Immunovant the world's 3621th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Immunovant from 2019 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$4.80 B-24.65%
2024NZ$6.37 B-33.86%
2023NZ$9.63 B166.84%
2022NZ$3.61 B151.77%
2021NZ$1.43 B-77.11%
2020NZ$6.26 B386.57%
2019NZ$1.28 B

End of Day market cap according to different sources

On Apr 2nd, 2025 the market cap of Immunovant was reported to be:

NZ$4.80 Billion
by Nasdaq info icon info icon
NZ$4.80 Billion
by CompaniesMarketCap info icon info icon
NZ$4.80 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.70 B-85.28%๐Ÿ‡บ๐Ÿ‡ธ USA